Stefano Natella joined Guggenheim Securities in 2017 as Senior Managing Director to lead its Equity Research group, bringing with him nearly three decades at Credit Suisse where he co-founded the Credit Suisse Research Institute and spearheaded influential global studies, including pioneering work on longevity and demographic change. His leadership helped shape industry understanding of how longer life expectancies and aging populations impact global markets, corporate strategy, and investment trends. A co-founder of the investment management firm Trinetra, and holding an M.A. in Electronic and Bio-Medical Engineering from the University of Florence and an MBA from Columbia University, Natella is widely recognized for combining rigorous technical analysis with thought leadership on long-term societal shifts, especially in the field of longevity.

Dr. Lucy Jones, DM (Oxon), MA Hons., BM BCh (Oxon), DFSRH, is a Senior Clinical Lecturer, Chief Medical Officer at Kalin Health LLC, and practicing clinician whose career bridges frontline medicine and translational research. Trained at the University of Oxford, where she earned both her medical degree and doctorate, she has led numerous clinical trials and experimental medicine studies in infection, immunity, and healthy aging. Her research, published in high-impact journals, focuses on immune aging and novel approaches to strengthening beneficial immune responses, with recent studies highlighting vulnerable populations in collaboration with international experts.

Sara Rotman is a celebrated entrepreneur and branding leader who founded the creative agency MODCo, which she grew into a nearly $100 million powerhouse working with iconic clients such as Tory Burch, Vera Wang, and Amazon. Known for her strategic, design-driven approach to brand strategy and storytelling, she has been dubbed a “branding guru” for her ability to shape long-term consumer engagement. Following a health crisis, she reinvented her career by founding Wellfounded Botanicals and building one of California’s largest woman-owned legal cannabis farms, blending her expertise in brand development with a passion for wellness and sustainable agriculture.

Dr. Jordan Shlain is a physician, entrepreneur, and respected voice on the future of healthcare. He is the founder and executive chairman of Private Medical, a physician-led concierge medical practice established in 2002. With locations in New York, San Francisco, Silicon Valley, Beverly Hills, Santa Monica, and Miami, Private Medical is known for its commitment to personalized, preventive, and relationship-based care for individuals and families. Dr. Shlain’s work at Private Medical centers on the belief that health is one of the most valuable assets a person holds—and that it should be managed with the same foresight, rigor, and care as any other long-term investment. His practice integrates advanced diagnostics, cutting-edge therapeutics, and long-term partnerships with leading specialists and institutions to guide members through complex decision-making with clarity and confidence. Beyond his clinical work, Dr. Shlain is a recognized pioneer in digital health. He founded Healthloop, one of the first AI-driven platforms for patient engagement, and serves as co-founder and chair of EatREAL, a nonprofit focused on transforming school food systems across the United States. He has been invited to speak at institutions including Stanford, Columbia, Princeton, and UC Berkeley, where he is known for his provocative, systems-level thinking about medicine, longevity, and human flourishing. Dr. Shlain earned his undergraduate degree from UC Berkeley and his MD from Georgetown University School of Medicine.

Prof. Dr. Katja Simon is an immunologist who leads the Cell Biology of Immunity Lab at the Max Delbrück Center for Molecular Medicine, where she explores how autophagy—the cellular recycling process—can rejuvenate the immune system and preserve immune cell function with age. Since moving from Oxford to MDC in 2022, she has pioneered research demonstrating that restoring autophagy using compounds like spermidine can revitalize memory T cell responses, particularly in older individuals. Her work blends mechanistic studies—from lab models to early clinical application—with a vision to translate cellular biology into improved immune health across the lifespan.

Dr. Ghada Alsaleh, PharmD, PhD is an Associate Professor at the University of Oxford’s NDORMS and a Versus Arthritis Career Development Fellow whose work bridges immunology, autophagy, and musculoskeletal aging. A pharmacist by training, she earned her MSc and PhD at the University of Strasbourg, where she revealed how fibroblast-like synoviocytes in rheumatoid arthritis act as active immune protagonists—not passive victims. Since joining Oxford in 2017, her groundbreaking research has uncovered how age-related declines in autophagy regulators like TFEB impair T- and B-cell memory responses, opening doors to anti-aging immune interventions. Her prolific output includes first-author publications in top-tier journals and the creation of the Oxford Space Innovation Lab to explore cellular biology under space conditions.

Bob founded Kalin Health in 2019/2020. Kalin Health is a healthcare startup focused on healthy aging. Kalin Health is dedicated to commercializing scientific research by attracting the best people in their field, rigorous scientific analysis, clinical testing of products and analyzing current consumer demand. Previously, Bob worked many years in financial services as a Chief Operating Officer, Chief Administrative Officer, Head of Strategy and Head of Expense Management. Bob has an MBA from Harvard University.

Alainn Bailey is a researcher and clinician specializing in nutrition, with a focus on the intersection of diet, health, and human performance. Her work centers on translating scientific findings into practical strategies for improving metabolic health, longevity, and overall well-being, with a particular interest in how nutrition can influence immune resilience and healthy aging. She has contributed to studies that explore dietary interventions and evidence-based approaches to optimizing long-term health outcomes.

Allan M. Katz served for about a decade as Chief Financial Officer at Guggenheim Securities, where he steered operational enhancements and streamlined expense management as the firm expanded its business and headcount. Before that, Katz held senior roles at Citigroup, Nomura, and Merrill Lynch, and began his career in accounting and consulting; in January 2025, he assumed the role of CFO at the Hanley Foundation where he provides the same level of strategic rigor while giving back to the community.